UCB - Ebitda

Prezzo Delle Azioni
239.00
Cambio Giornaliero
-7.30 -2.96%
Mensile
-5.87%
Annuale
59.65%
Q2 Previsione
233.96




Ebitda Cambiamento Data
Alcon AG USD 317M 337M 2025-12
Almirall EUR 114.07M 60.37M 2025-12
Amarin USD 12.54M 28.57M 2025-06
argenx SE USD 387.05M 99.02M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
Bayer EUR 1.97B 457M 2025-12
Galapagos EUR 2.42M 161.13M 2025-09
Genmab DKK 186M 291M 2025-12
GlaxoSmithKline GBP 3.36B 179M 2025-09
GRIFOLS EUR 347.24M 58.35M 2025-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.44B 263M 2025-12
Novartis USD 4.77B 1.11B 2025-12
Orion EUR 130.4M 212.6M 2026-03
Recordati EUR 247.15M 421K 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
UCB EUR 1.6B 570M 2025-12
Unibail Rodamco EUR 1.02B 71.7M 2024-12